Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Annexin A9 (ANXA9) biomarker and therapeutic target in epithelial cancer

Patent ·
OSTI ID:1055690
 [1];  [2];  [3];  [4]
  1. El Cerrito, CA
  2. San Ramon, CA
  3. San Mateo, CA
  4. San Francisco, CA
Amplification of the ANXA9 gene in human chromosomal region 1q21 in epithelial cancers indicates a likelihood of both in vivo drug resistance and metastasis, and serves as a biomarker indicating these aspects of the disease. ANXA9 can also serve as a therapeutic target. Interfering RNAs (iRNAs) (such as siRNA and miRNA) and shRNA adapted to inhibit ANXA9 expression, when formulated in a therapeutic composition, and delivered to cells of the tumor, function to treat the epithelial cancer.
Research Organization:
University of California (Oakland, CA)
Sponsoring Organization:
USDOE
DOE Contract Number:
AC02-05CH11231
Assignee:
The Regents of the University of California (Oakland, CA)
Patent Number(s):
8,198,254
Application Number:
12/412,304
OSTI ID:
1055690
Country of Publication:
United States
Language:
English

References (43)

Online Access to CGH Data of DNA Sequence Copy Number Changes journal August 2000
ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization. journal June 1992
Knockdown of Mouse Adult β-Globin Gene Expression in MEL Cells by Retrovirus Vector-Mediated RNA Interference journal January 2004
Diagnostic Evaluation of HER-2 as a Molecular Target: An Assessment of Accuracy and Reproducibility of Laboratory Testing in Large, Prospective, Randomized Clinical Trials journal September 2005
Gene Expression Profiles in Paraffin-Embedded Core Biopsy Tissue Predict Response to Chemotherapy in Women With Locally Advanced Breast Cancer journal October 2005
Gene expression profiling predicts clinical outcome of breast cancer journal January 2002
DNA hypermethylation in tumorigenesis: epigenetics joins genetics journal April 2000
End-sequence profiling: Sequence-based analysis of aberrant genomes journal June 2003
Repeated observation of breast tumor subtypes in independent gene expression data sets journal June 2003
Antitumor Activity of Small Interfering RNA/Cationic Liposome Complex in Mouse Models of Cancer journal November 2004
Overview of Cancer Epigenetics journal July 2005
Overexpression and functional alterations of the EphA2 tyrosine kinase in cancer journal February 2003
Small RNA: can RNA interference be exploited for therapy? journal October 2003
Genome-wide analysis of DNA copy-number changes using cDNA microarrays journal September 1999
Quantitative analysis of chromosomal CGH in human breast tumors associates copy number abnormalities with p53 status and patient survival journal July 2001
Comprehensive Profiling of 8p11-12 Amplification in Breast Cancer journal December 2005
Anti-Genes: siRNA, Ribozymes and Antisense journal October 2004
Differential Regulation of EphA2 in Normal and Malignant Cells journal April 2003
Genomic and Expression Analysis of the 8p11–12 Amplicon in Human Breast Cancer Cell Lines journal January 2004
RNA interference: from model organisms towards therapy for neural and neuromuscular disorders journal October 2004
Prognostic Role of a Multigene Reverse Transcriptase-PCR Assay in Patients with Node-Negative Breast Cancer Not Receiving Adjuvant Systemic Therapy journal May 2005
Prognostic Relevance of Gene Amplifications and Coamplifications in Breast Cancer journal December 2004
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications journal September 2001
Protein elongation factor EEF1A2 is a putative oncogene in ovarian cancer journal June 2002
Coupled analysis of gene expression and chromosomal location journal March 2005
Specific Keynote: Genome Copy Number Abnormalities in Ovarian Cancer journal January 2003
Amplification of a 280-Kilobase Core Region at the ERBB2 Locus Leads to Activation of Two Hypothetical Proteins in Breast Cancer journal November 2003
Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. journal March 1994
Gene therapy for human small-cell lung carcinoma by inactivation of Skp-2 with virally mediated RNA interference journal September 2004
A molecular signature of metastasis in primary solid tumors journal December 2002
Amplification of 20q13 locus in breast cancer: -Defining the minimal region journal October 1994
Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle journal October 2004
The Hallmarks of Cancer journal January 2000
Molecular portraits of human breast tumours journal August 2000
Enhanced paclitaxel cytotoxicity and prolonged animal survival rate by a nonviral-mediated systemic delivery of E1A gene in orthotopic xenograft human breast cancer journal July 2004
Array Comparative Genomic Hybridization Analysis of Genomic Alterations in Breast Cancer Subtypes journal December 2004
Computational BAC clone contig assembly for comprehensive genome analysis journal January 2004
Chromosome aberrations in solid tumors journal July 2003
EphA2 Expression Is Associated with Aggressive Features in Ovarian Carcinoma journal August 2004
The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers journal October 2004
High resolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridization journal November 2005
Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors journal September 2002
Distinctive gene expression patterns in human mammary epithelial cells and breast cancers journal August 1999

Similar Records

Breast cancer stem cells, EMT and therapeutic targets
Journal Article · Fri Oct 10 00:00:00 EDT 2014 · Biochemical and Biophysical Research Communications · OSTI ID:22416786

Predictive and therapeutic markers in ovarian cancer
Patent · Tue Mar 26 00:00:00 EDT 2013 · OSTI ID:1082960

Small interfering RNA targeting ILK inhibits metastasis in human tongue cancer cells through repression of epithelial-to-mesenchymal transition
Journal Article · Thu Aug 01 00:00:00 EDT 2013 · Experimental Cell Research · OSTI ID:22271327

Related Subjects